{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:55:31Z","timestamp":1773266131517,"version":"3.50.1"},"reference-count":131,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.clinre.2011.02.007","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T07:41:06Z","timestamp":1302853266000},"page":"446-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Liver transplantation in PBC and PSC: Indications and disease recurrence"],"prefix":"10.1016","volume":"35","author":[{"given":"Marco","family":"Carbone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2011.02.007_bib0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.lts.2003.09.018","article-title":"Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry","volume":"9","author":"Adam","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.clinre.2011.02.007_bib0015","unstructured":"United Network for Organ Sharing (UNOS). Available at http:\/\/www.unos.org\/."},{"key":"10.1016\/j.clinre.2011.02.007_bib0020","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2011.02.007_bib0030","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1089-3261(03)00099-0","article-title":"Liver transplantation for primary biliary cirrhosis","volume":"7","author":"MacQuillan","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2011.02.007_bib0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0040","unstructured":"Nordic Liver Transplant Registry. Available at: www.scandiatransplant.org."},{"key":"10.1016\/j.clinre.2011.02.007_bib0045","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/jlts.2003.50169","article-title":"Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list","volume":"9","author":"Brandsaeter","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0050","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1080\/00365520310006009","article-title":"Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries","volume":"38","author":"Brandsaeter","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0055","first-page":"315","article-title":"An analysis of the OPTN\/UNOS Liver Transplant Registry","volume":"18","author":"Futagawa","year":"2004","journal-title":"Clin Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0060","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases - an analysis of the UNOS Database","volume":"14","author":"Kashyap","year":"2010","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.clinre.2011.02.007_bib0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0168-8278(99)80075-0","article-title":"Optimal timing of liver transplantation for patients with primary biliary cirrhosis: use of prognostic modelling","volume":"30","author":"Christensen","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0070","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. European Association for the Study of the Liver. J Hepatol 2009;51:237\u2013267.","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"10.1016\/j.clinre.2011.02.007_bib0075","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1089-3261(03)00101-6","article-title":"Primary biliary cirrhosisd presentation and diagnosis","volume":"7","author":"Leuschner","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2011.02.007_bib0080","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1572-0241.2000.01857.x","article-title":"Impact of fatigue on the quality of life of patients with primary biliary cirrhosis","volume":"95","author":"Huet","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.43.5.705","article-title":"Fatigue in primary biliary cirrhosis","volume":"43","author":"Cauch-Dudek","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.02.007_bib0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1467-842X.2001.tb00594.x","article-title":"Quality of life in HCV-infection: lack of association with ALT levels","volume":"25","author":"Miller","year":"2001","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.clinre.2011.02.007_bib0095","first-page":"1606","article-title":"Fatigue associated with chronic liver disease: a riddle wrapped in a mystery inside an enigma","volume":"22","author":"Jones","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0100","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.510250239","article-title":"Is fatigue associated with cholestasis mediated by altered central neurotransmission?","volume":"25","author":"Jones","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0105","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/0016-5085(95)90709-2","article-title":"The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids","volume":"108","author":"Bergasa","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0110","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.1840110526","article-title":"The pruritus of cholestasis: from bile acids to opiate agonists","volume":"11","author":"Jones","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0115","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/bmj.297.6662.1501","article-title":"Opioid peptides and primary biliary cirrhosis","volume":"297","author":"Thornton","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.clinre.2011.02.007_bib0120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/gast.2002.31878","article-title":"Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats","volume":"122","author":"Burak","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0125","doi-asserted-by":"crossref","unstructured":"Bjornsson E et al. Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up. Liver Int 2010;30(2):251\u20138 [doi:10.1111\/j.1478-3231.2009.02160.x].","DOI":"10.1111\/j.1478-3231.2009.02160.x"},{"key":"10.1016\/j.clinre.2011.02.007_bib0130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2010.05.026","article-title":"The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: results of a 9-year follow-up","volume":"53","author":"Jones","year":"2010","journal-title":"J Hepatol"},{"issue":"70","key":"10.1016\/j.clinre.2011.02.007_bib0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2036.2003.01398.x","article-title":"Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial","volume":"17","author":"Prince","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2011.02.007_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-230X-4-13","article-title":"Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomized controlled trial [iSRCTN88246634]","volume":"4","author":"Ter Borg","year":"2004","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0145","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s10620-006-9397-5","article-title":"Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial","volume":"51","author":"Talwalkar","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2011.02.007_bib0150","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/hep.20698","article-title":"A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue","volume":"41","author":"Theal","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1046\/j.1365-2036.2001.01018.x","article-title":"Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients","volume":"15","author":"Battezzati","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2011.02.007_bib0160","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1007\/s10620-008-0613-3","article-title":"Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience","volume":"54","author":"Ian Gan","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2011.02.007_bib0165","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2006.03048.x","article-title":"Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy","volume":"24","author":"Babatin","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2011.02.007_bib0170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.510290229","article-title":"Quality of life before and after liver transplantation for cholestatic liver disease","volume":"29","author":"Gross","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0175","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jhep.2005.09.004","article-title":"The pruritus of cholestasis","volume":"43","author":"Bergasa","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0180","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2011.02.007_bib0185","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","article-title":"The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus","volume":"102","author":"Tandon","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cld.2008.02.013","article-title":"Pruritus in primary biliary cirrhosis: pathogenesis and therapy","volume":"12","author":"Bergasa","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2011.02.007_bib0195","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/jhep.2002.31872","article-title":"Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis","volume":"35","author":"Boberg","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0200","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hep.510290607","article-title":"The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis","volume":"29","author":"Kim","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2011.02.007_bib0205","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/hep.510250330","article-title":"A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease","volume":"25","author":"Ricci","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis - AASLD practice guidelines","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2011.02.007_bib0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am. J. Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2011.02.007_bib0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.clinre.2011.02.007_bib0225","first-page":"685","article-title":"Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study","volume":"8","author":"Okolicsanyi","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0230","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/01.pas.0000213286.65907.ea","article-title":"Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy","volume":"30","author":"Abraham","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0240","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/jlts.2000.18688","article-title":"Early detection and treatment of cholangiocarinoma","volume":"6","author":"Gores","year":"2000","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.clinre.2011.02.007_bib0245","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1091-255X(99)80051-1","article-title":"Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis","volume":"3","author":"Ahrendt","year":"1999","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.clinre.2011.02.007_bib0250","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1572-0241.2007.01220.x","article-title":"Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis","volume":"102","author":"Bjornsson","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.clinre.2011.02.007_bib0255","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1097\/01.tp.0000187106.29908.2b","article-title":"Extended indications in living-donor liver transplantation: bile duct cancer","volume":"80","author":"Jonas","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.clinre.2011.02.007_bib0260","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00104-006-1177-4","article-title":"Surgical therapy of hilar cholangiocarcinoma","volume":"77","author":"Lang","year":"2006","journal-title":"Chirurg"},{"key":"10.1016\/j.clinre.2011.02.007_bib0265","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.sla.0000149426.08580.a1","article-title":"Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC) \u2013 when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period","volume":"241","author":"Lang","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.clinre.2011.02.007_bib0270","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients","volume":"69","author":"Meyer","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.clinre.2011.02.007_bib0275","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/00000658-199611000-00007","article-title":"Surgical treatment in proximal bile duct cancer: a single-center experience","volume":"224","author":"Pichlmayr","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.clinre.2011.02.007_bib0280","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.clinre.2011.02.007_bib0285","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","article-title":"Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature","volume":"7","author":"Shimoda","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0290","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clinre.2011.02.007_bib0295","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/lv.2000.6143","article-title":"Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma","volume":"6","author":"De Vreede","year":"2000","journal-title":"Liver Transplant"},{"issue":"12","key":"10.1016\/j.clinre.2011.02.007_bib0300","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/01.tp.0000253551.43583.d1","article-title":"Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"82","author":"Heimbach","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.clinre.2011.02.007_bib0305","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1002\/lt.20965","article-title":"Model for End-Stage Liver Disease (MELD) exception for cholangiocarcinoma or biliary dysplasia","volume":"12","author":"Gores","year":"2006","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.clinre.2011.02.007_bib0310","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1040420","article-title":"Relationship of inflammatory bowel disease and primary sclerosing cholangitis","volume":"11","author":"Fausa","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2011.02.007_bib0315","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF01213311","article-title":"Primary sclerosing cholangitis in Japan \u2013 analysis of 192 cases","volume":"32","author":"Takikawa","year":"1997","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broome","year":"2006","journal-title":"Sem Liv Dis"},{"key":"10.1016\/j.clinre.2011.02.007_bib0325","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.02.007_bib0330","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/gut.43.5.639","article-title":"Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis","volume":"43","author":"Papatheodoridis","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.02.007_bib0335","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00042737-200306000-00013","article-title":"Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis","volume":"15","author":"Van de Vrie","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0340","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/jhep.2002.30695","article-title":"Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"35","author":"Dvorchik","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0345","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00042737-200512000-00018","article-title":"The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation","volume":"17","author":"Ho","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2036.2003.01613.x","article-title":"Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens","volume":"18","author":"Haagsma","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2011.02.007_bib0355","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00007890-199802150-00017","article-title":"Clinical course and management of inflammatory bowel disease after liver transplantation","volume":"65","author":"Befeler","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.clinre.2011.02.007_bib0360","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01318204","article-title":"Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis","volume":"36","author":"Gavaler","year":"1991","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2011.02.007_bib0365","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00000658-199206000-00006","article-title":"The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation","volume":"215","author":"Shaked","year":"1992","journal-title":"Ann Surg"},{"key":"10.1016\/j.clinre.2011.02.007_bib0370","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.TP.0000058744.34965.38","article-title":"Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"75","author":"Vera","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.clinre.2011.02.007_bib0375","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0002-9610(98)00141-X","article-title":"Colon carcinoma in patients undergoing liver transplantation","volume":"176","author":"Fabia","year":"1998","journal-title":"Am J Surg"},{"key":"10.1016\/j.clinre.2011.02.007_bib0380","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.surg.2005.07.014","article-title":"Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case control study","volume":"138","author":"Gorgun","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.clinre.2011.02.007_bib0385","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s11605-008-0528-5","article-title":"Proctocolectomy-ileal pouch-anal anastomosis for ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a multi-institutional analysis","volume":"12","author":"Cho","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.clinre.2011.02.007_bib0390","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.transproceed.2009.03.027","article-title":"Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis","volume":"41","author":"Bosso","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinre.2011.02.007_bib0395","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0025-6196(11)64839-8","article-title":"Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy","volume":"71","author":"Kartheuser","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinre.2011.02.007_bib0400","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s10350-004-6655-5","article-title":"Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study","volume":"46","author":"Stahlberg","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clinre.2011.02.007_bib0405","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2011.02.007_bib0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198201073060101","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"306","author":"Neuberger","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2011.02.007_bib0415","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0420","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0425","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0430","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"LiermannGarcia","year":"2001","journal-title":"Hepatology (Baltimore MD)"},{"key":"10.1016\/j.clinre.2011.02.007_bib0435","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0440","first-page":"176A","article-title":"Transplantation for primary biliary cirrhosis: disease recurrence and outcome in 421 patients","volume":"26","author":"Abu-Elmagd","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0445","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.clinre.2011.02.007_bib0450","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/jlts.2003.50132","article-title":"The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation","volume":"9","author":"Levitsky","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0455","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a long-term pathologic study","volume":"9","author":"Khettry","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0460","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/00007890-199805270-00008","article-title":"Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation","volume":"65","author":"Sebagh","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.clinre.2011.02.007_bib0465","first-page":"35","article-title":"Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?","volume":"13","author":"Jacob","year":"2008","journal-title":"Ann Transplant"},{"key":"10.1016\/j.clinre.2011.02.007_bib0470","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"4","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0475","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.clinre.2011.02.007_bib0480","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0485","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/PAS.0b013e3181622490","article-title":"Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests","volume":"32","author":"Abraham","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0490","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8278(05)80056-X","article-title":"Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation","volume":"20","author":"Klein","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0495","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/hep.1840080439","article-title":"Pathologic analysis of liver transplantation for primary biliary cirrhosis","volume":"8","author":"Demetris","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0500","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/lt.21781","article-title":"Late protocol liver biopsies in the liver allograft: a neglected investigation?","volume":"15","author":"Mells","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0505","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0168-8278(05)80206-5","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression","volume":"17","author":"Wong","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0510","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-8278(05)80244-2","article-title":"Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation","volume":"18","author":"Hubscher","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0515","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jlts.2001.25357","article-title":"Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study","volume":"7","author":"Hashimoto","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0520","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0016-5085(88)90373-3","article-title":"Pilot study of cyclosporine A in patients with symptomatic primary biliary cirrhosis","volume":"95","author":"Minuk","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0525","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0002-9440(10)64089-8","article-title":"Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection","volume":"158","author":"Lunz","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0530","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00705-002-0826-2","article-title":"Immunophilins and HIV-1 infection","volume":"147","author":"Minder","year":"2002","journal-title":"Arch Virol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0535","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-5793(00)02083-4","article-title":"Regulation of tumour necrosis factor for cytotoxicity by calcineurin","volume":"483","author":"Kantrow","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinre.2011.02.007_bib0540","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1096\/fj.01-0206fje","article-title":"The mitochondrial permeability transition initiates autophagy rat hepatocytes","volume":"15","author":"Elmore","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.clinre.2011.02.007_bib0545","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0550","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity","volume":"16","author":"Manousou","year":"2010","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.clinre.2011.02.007_bib0555","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-8278(96)80001-8","article-title":"Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression","volume":"24","author":"Dmitrewski","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0560","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.transproceed.2008.10.095","article-title":"Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal","volume":"41","author":"Campsen","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinre.2011.02.007_bib0565","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0570","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant","volume":"11","author":"Guy","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0575","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hep.22435","article-title":"Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database","volume":"48","author":"Balan","year":"2008","journal-title":"Hepatology (Baltimore MD)"},{"key":"10.1016\/j.clinre.2011.02.007_bib0580","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/lt.21118","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Hashimoto","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0585","first-page":"127","article-title":"Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection?","volume":"1","author":"Lerut","year":"1988","journal-title":"Transpl Int"},{"key":"10.1016\/j.clinre.2011.02.007_bib0590","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.1840200214","article-title":"Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis?","volume":"20","author":"Harrison","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0595","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2214\/ajr.166.5.8615253","article-title":"Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease","volume":"166","author":"Sheng","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0600","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0605","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0610","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0615","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.transproceed.2004.07.041","article-title":"Living related donor liver transplantation for primary sclerosing cholangitis with hepatocellular carcinoma and Crohn's disease: a case report","volume":"36","author":"Oya","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinre.2011.02.007_bib0620","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1432-2277.1999.tb00626.x","article-title":"Native hepatectomy after auxiliary partial orthotopic liver transplantation","volume":"12","author":"Kaibori","year":"1999","journal-title":"Transpl Int"},{"key":"10.1016\/j.clinre.2011.02.007_bib0625","first-page":"2951","article-title":"Living-related auxiliary partial orthotopic liver transplantation for primary sclerosing cholangitis: subsequent removal of the native liver","volume":"46","author":"Ikegami","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.clinre.2011.02.007_bib0630","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ndt\/16.1.166","article-title":"Three cases of sequential liver-kidney transplantation from living-related donors","volume":"16","author":"Nakamura","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinre.2011.02.007_bib0635","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2011.02.007_bib0640","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.clinre.2011.02.007_bib0645","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10620-009-0773-9","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.clinre.2011.02.007_bib0650","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1572-0241.2004.04050.x","article-title":"Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC","volume":"99","author":"Maheshwari","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.02.007_bib0655","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.21280","article-title":"Liver biopsy interpretation for causes of late liver allograft dysfunction","volume":"44","author":"Demetris","year":"2006","journal-title":"Hepatology"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740111000647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740111000647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:11:57Z","timestamp":1761894717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740111000647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":131,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S2210740111000647"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2011.02.007","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver transplantation in PBC and PSC: Indications and disease recurrence","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2011.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}